Telemedicine in an Academic Movement Disorders Center during COVID-19
| Autor: | Sosi Papazian, Daniel Bartholomew, Laura Scorr, Stewart A. Factor, Christine D. Esper, Gregory J. Esper |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Telemedicine Neurology Movement disorders Neurosciences. Biological psychiatry. Neuropsychiatry Disease 03 medical and health sciences 0302 clinical medicine Patient satisfaction 0502 economics and business Pandemic Health care medicine Medical diagnosis RC346-429 business.industry pandemic 05 social sciences covid-19 Emergency medicine movement disorders Original Article Neurology (clinical) telemedicine Neurology. Diseases of the nervous system medicine.symptom business 050203 business & management 030217 neurology & neurosurgery RC321-571 |
| Zdroj: | Journal of Movement Disorders, Vol 14, Iss 2, Pp 119-125 (2021) Journal of Movement Disorders |
| ISSN: | 2093-4939 |
| Popis: | Objective: Telemedicine has rapidly gained momentum in movement disorder neurology during the coronavirus disease (COVID-19) pandemic to preserve clinical care while mitigating the risks of in-person visits. We present data from the rapid implementation of virtual visits in a large, academic, movement disorder practice during the COVID-19 pandemic. Methods: We describe the strategic shift to virtual visits and retrospectively examine elements that impacted the ability to switch to telemedicine visits using historical prepandemic in-person data as a comparator, including demographics, distance driven, and diagnosis distribution, with an additional focus on patients with deep brain stimulators. Results: A total of 686 telemedicine visits were performed over a five-week period (60% of those previously scheduled for in-office visits). The average age of participants was 65 years, 45% were female, and 73% were Caucasian. Men were more likely to make the transition (p = 0.02). Telemedicine patients lived farther from the clinic than those seen in person (66.47 km vs. 42.16 km, p < 0.001), age was not associated with making the switch, and patient satisfaction did not change. There was a significant shift in the distribution of movement disorder diagnoses seen by telemedicine compared to prepandemic in-person visits (p < 0.001). Patients with deep brain stimulators were more likely to use telemedicine (11.5% vs. 7%, p < 0.001). Conclusion: Telemedicine is feasible, viable and relevant in the care of movement disorder patients, although health care disparities appear evident for women and minorities. Patients with deep brain stimulators preferred telemedicine in our study. Further study is warranted to explore these findings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|